Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Better Therapeutics, Inc. - Common Stock (NQ: BTTX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Better Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Dow Jumps Over 100 Points; US Small Business Optimism Index Tops Estimates
U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.40% to 34,080.13 while the NASDAQ rose 0.23% to... 
Via Benzinga
Why Are Better Therapeutics Shares Gaining Today?
Better Therapeutics Inc (NASDAQ: BTTX) shares are trading higher after the FDA approved the company's AspyreRx (formerly BT-001), a prescription-only digital treatment to provide cognitive behavioral... 
Via Benzinga
Why Is Iovance Biotherapeutics (IOVA) Stock Down 10% Today?
Iovance Biotherapeutics (IOVA) stock is sliding lower on Tuesday after the company announced details of a public share offering. 
Via InvestorPlace
Why Is EzFill (EZFL) Stock Down 5% Today?
EzFill (EZFL) stock is taking a beating on Tuesday despite the company releasing positive data from the second quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Better Therapeutics: Q1 Earnings Insights
Via Benzinga
Better Therapeutics's Earnings: A Preview
Via Benzinga
A Preview Of Better Therapeutics's Earnings
Via Benzinga
Why Is Better Therapeutics (BTTX) Stock Up 39% Today?
Better Therapeutics (BTTX) stock is taking off on Tuesday as investors react to approval from the FDA for a Type 2 diabetes treatment. 
Via InvestorPlace
Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarket
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another breakdown of the biggest pre-market stock movers as we check out all of the shares rising and falling on Tuesday! 
Via InvestorPlace
Better Therapeutics Receives FDA Authorization for AspyreRx™ to Treat Adults with Type 2 Diabetes
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics Announces Upcoming Poster Presentation at EASL Congress 2023 in Vienna, Austria
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
From Better Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023
From Better Therapeutics, Inc.
Via Business Wire
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers PLx Pharma Inc. (NASDAQ: PLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursday. 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Better Therapeutics Announces $6.5MM Private Placement
From Better Therapeutics, Inc.
Via Business Wire
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront... 
Via Benzinga
Better Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics to Participate in Two Upcoming Investor Conferences
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics Posts Encouraging Data Establishing Proof-Of-Concept For Prescription Digital Therapy Platform
Via Benzinga
Better Therapeutics Completes Exploratory Trial for Fatty Liver Disease and Announces Positive Topline Results
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics to Participate in BTIG Digital Health Forum
From Better Therapeutics, Inc.
Via Business Wire
PDS Biotechnology To Rally Around 129%? Here Are 5 Other Price Target Changes For Tuesday
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS